Back to School: How biopharma can reboot drug development. Access exclusive analysis here

MediciNova proposes follow-on

MediciNova (MNOV; Osaka:4875) proposed to sell 6 million shares in a follow-on

Read the full 128 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE